Your SlideShare is downloading. ×

Ankylosing Spondylitis - Epidemiology Forecast to 2022


Published on

Market Research Reports, Inc. has announced the addition of “EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022” research report to their offering. See more at:

Market Research Reports, Inc. has announced the addition of “EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2022” research report to their offering. See more at:

Published in: Business, Health & Medicine

1 Like
  • Be the first to comment

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. Category : Pharma & Healthcare All logos and Images mentioned on this slide belong to their respective owners.
  • 2. Introduction to Report  Launch Date: March 27, 2014  Number of Pages: 49  Geography Coverage: Global  Available Format: PDF Price For Single User License: USD 3,995 Price For Site User License: USD 7,990 Price For Global User License: USD 11,985 Delivery Time: Within 24 Hours (During Working Days)
  • 3. About the Report Ankylosing spondylitis is a systemic, chronic, and progressive inflammatory arthritis in the family of seronegativespondyloarthritis, and is one of the most common rheumatic conditions throughout the world. Ankylosing spondylitis primarily affects the spine and sacroiliac joints, with involvement with other joints in the shoulders, hips, and knees. It can progress into severe inflammation that fuses the spine, leading to permanent painful stiffness of the back. Although treatment helps in relieving pain and stiffness and keeps the spine flexible, the disease is irreversible and people with the disorder have to cope with symptoms throughout their lives. Global prevalence of the disease ranges from 0.01%–1.40%, with higher prevalence in western European Caucasian populations.
  • 4. Research Findings Publisher epidemiologists forecast an increase in the diagnosed prevalent cases of ankylosing spondylitis in the 7MM, from 818,456 diagnosed prevalent cases in 2012 to 850,849 diagnosed prevalent cases in 2022, with an annual growth rate (AGR) of 0.40%. Throughout the forecast period, the US will have the highest number of diagnosed prevalent cases of ankylosing spondylitis, with 608,813 diagnosed prevalent cases in 2022. This forecast provides detailed and clinically relevant segmentations of ankylosing spondylitis prevalent cases in the 7MM. These segmentations allow for an improved understanding of the disease epidemiology and the ability to focus on specific subgroups. Trends in the diagnosed prevalent cases of ankylosing spondylitis are a direct result of changing population demographics in the 7MM. The analysis is strengthened by the use of sources with validated diagnostic criteria and uniform methodology in each market, allowing for a meaningful comparison of the diagnosed prevalent cases of ankylosing spondylitis across the 7MM.
  • 5. Scope The Ankylosing Spondylitis EpiCast Report provides an overview of the risk factors, comorbidities, and global trends ofankylosing spondylitis in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan).It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of ankylosing spondylitissegmented by age (beginning at 15 years and ending at 65 years and older), sex, and HLA-B27 seropositivitystatus in these markets. The ankylosing spondylitisepidemiology report is written and developed by Mastersand PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
  • 6. Reasons To Buy Develop business strategies by understanding the trends shaping and driving the global ankylosing spondylitismarket. Quantify patient populations in the globalankylosing spondylitismarket to improve product design, pricing, and launch plans. Organize sales and marketing efforts by identifying the sex and age groupsthat present the best opportunities for ankylosing spondylitistherapeutics in each of the markets covered.
  • 7. Report Coverage Table of Contents Introduction Epidemiology Appendix
  • 8. Custom Research:  Are you an industry professional, entrepreneur, venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research. For Any Customization Related query Visit IdeaCenter @
  • 9. How To Buy This Report? Visit following URL to see Table of Content and purchase this publication: About Market Research Reports, Inc. Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : Phone: +1 302-703-7787 (USA) +91-8762746600 (India)